Clinical Trial Update: Comparison of the Efficacy and Safety of 4 vs. 8 Treatments With Tepezza (Teprotumumab) for Thyroid Eye Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing 4 versus 8 Tepezza treatment regimens for Thyroid Eye Disease. The trial is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• TEPEZZA (teprotumumab)

Snippet

Sponsor: Sheba Medical Center | Conditions: Thyroid Eye Disease, Thyroid Eye Disease, TED | Phase 4 | Status: NOT_YET_RECRUITING